Adjusted net earnings were $25.4 billion* To increase access million, and launched 15 major products Adjusted diluted net earnings per share was $9.92*, an increase of 11.1% from 2022.
Pixs30 Nude OnlyFans Leaks - Photo #3784530 - Fapopedia
Johnson & johnson annual research and development expenses for 2023 were $15.085b, a 6.72% increase from 2022
Johnson & johnson annual research and development expenses for 2022 were $14.135b, a 0.99% decline from 2021.
In 2024, johnson & johnson spent more than 17 billion u.s Dollars on research and development This is a significant increase compared to 2014 when the company spent 8.5 billion dollars on. Johnson & johnson and its subsidiaries (the company) have approximately 152,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field.
